News | March 20, 2026
Clariant boosts US pharmaceutical production with Clear Lake expansion
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
He has more than 285 publications with 7,600 citations, 80 students have already been awarded Ph. D. degree under his able guidance and 20 postdoctoral associates have worked in his group
Subscribe To Our Newsletter & Stay Updated
